Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1130 result(s) found, displaying 826 to 850

  • AusPAR: Cobicistat

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Cobicistat

  • AusPAR: Elvitegravir

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Elvitegravir

  • AusPAR: Ivacaftor

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ivacaftor

  • AusPAR: Retapamulin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Retapamulin

  • AusPAR: Romidepsin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Romidepsin

  • AusPAR: Fentanyl citrate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Fentanyl citrate

  • AusPAR: Ivermectin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ivermectin

  • AusPAR: Adalimumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Adalimumab (rch)

  • AusPAR: Interferon beta-1a

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Interferon beta-1a

  • AusPAR: Pertuzumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Pertuzumab (rch)

  • AusPAR: Nabiximols

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nabiximols

  • AusPAR: Rivaroxaban

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rivaroxaban

  • AusPAR: Botulinum toxin type A

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Botulinum toxin type A

  • AusPAR: Dimethyl fumarate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Dimethyl fumarate

  • AusPAR: Atazanavir

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Atazanavir

  • AusPAR: Retigabine

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Retigabine

  • AusPAR: Clobazam

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Clobazam

  • AusPAR: Eplerenone

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Eplerenone